Proponol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proponol

Property Description
Active ingredient Piroxicam
Form Capsules, tablets, gels, injectables
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Symptomatic relief from pain and inflammation
Origin Synthetic

Proponol is a trade name for a synthetic, prescription-only medicine whose sole active ingredient is Piroxicam. It is fundamentally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), and its primary general purpose is to provide relief from pain and inflammation.


What Type of Medicine is Proponol?

Proponol is a single-ingredient agent classified in the Nonsteroidal Anti-inflammatory Drug (NSAID) class, specifically belonging to the Oxicam chemical subgroup. This classification defines its broad pharmacological actions as having anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing) properties. The active substance, Piroxicam, is a synthetic small molecule with the chemical formula C15H13N3O4S. The Oxicam structure contributes to the drug's characteristic long half-life. This pharmacological differentiation is clinically recognized for supporting less frequent administration compared to many other agents in the broader NSAID category.


What is Piroxicam, the Active Ingredient?

Piroxicam functions as a non-selective Cyclooxygenase (COX) inhibitor, meaning it blocks the activity of the COX enzymes necessary for the body's synthesis of prostaglandins. This inhibitory action on the prostaglandin synthesis pathway is the core functional mechanism that allows Proponol to mitigate pain and inflammation. The therapeutic action of Piroxicam is directly related to this mechanism, providing effective symptomatic relief from inflammatory responses. This mechanism is typically employed to alleviate discomfort associated with conditions like general painful inflammatory responses.


What is the General Purpose of Proponol?

The general purpose of Proponol is to alleviate the core symptoms of painful inflammatory conditions by simultaneously reducing swelling and providing pain relief. The medicine is available in varied dosage forms, including solid oral forms like capsules and tablets, as well as preparations for topical use, such as gel, and injectable forms. This range of presentations allows the Piroxicam to be administered via the oral route, the dermal route, or parenteral routes to address systemic or localized needs.

What side effects are possible with Proponol?

Possible Side Effects and Safety Information

Propranolol’s safety profile is officially documented with adverse reactions categorized by system organ class and frequency. The majority of reported side effects are generally mild and transient, though serious, clinically significant reactions are documented and require immediate attention.


Adverse Reaction Scope

Classification Examples of Reactions
Common (based on regulatory-cited sources) Tiredness, dizziness, cold extremities, nausea, vomiting, diarrhea, sleep disturbances, and nightmares.
Serious / Clinically Significant Severe bradycardia, heart block, bronchospasm (especially in patients with asthma), decompensated heart failure, severe allergic reactions (including anaphylaxis), and Stevens Johnson Syndrome.
System-Organ Classes Primarily Cardiovascular, Nervous System, Gastrointestinal, Psychiatric, and Skin.

Safety-Related Restrictions and Considerations

Propranolol is contraindicated in patients with certain conditions, including bronchial asthma or bronchospasm, severe bradycardia, second- or third-degree heart block (without a pacemaker), and overt cardiac failure. It is also restricted in cases of cardiogenic shock.

Population-Specific Warnings:

  • Diabetes: Propranolol can mask the clinical signs of acute hypoglycemia (e.g., fast heart rate, tremor), prolonging the recovery from low blood sugar. Caution and frequent monitoring are required.
  • Infants/Neonates: Risk of hypoglycemia, especially in premature infants or during stress/poor feeding.

Dose and Exposure Patterns: Abrupt cessation of therapy can trigger a withdrawal syndrome, potentially worsening angina and increasing the risk of myocardial infarction. Dosage must be tapered slowly under medical supervision. Overdose risk is high, presenting with profound bradycardia, hypotension, and central nervous system effects.

Overdose and Emergency Response

Overdose and When to Seek Help

A Piroxicam (Proponol) overdose may manifest with documented clinical signs primarily affecting the digestive and nervous systems. Initial symptoms can include stomach pain, nausea, vomiting, diarrhea, severe headache, confusion, drowsiness, and ringing in the ears (tinnitus).

When Urgent Medical Attention Is Required

Immediate emergency services must be contacted if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. These actions are mandated because official regulatory documents describe the potential for severe, life-threatening outcomes, including shock (dangerously low blood pressure), coma, and acute renal failure (little to no urine production). Individuals with pre-existing kidney or liver disease are noted to be at a higher risk of serious adverse effects following an NSAID overdose.

Official Management Strategy

Management of a Piroxicam overdose is determined by official guidance as symptomatic and supportive, as no specific antidote is known. Procedures documented in regulatory texts include the use of activated charcoal, gastric lavage, and intravenous fluid administration. Continuous monitoring is required, encompassing vital signs, blood and urine tests, and an ECG. Specialized interventions, such as endoscopy or kidney dialysis, may be necessary to manage severe systemic complications.

Therapeutic Uses of Proponol

Proponol (Piroxicam) is primarily used for symptomatic management of conditions characterized by inflammatory or irritative states where supportive relief is needed. The medicine is commonly used to help with symptoms related to physical discomfort.

This medication is applied in clinical settings that involve acute or unstable symptom patterns, as well as for the long-term symptomatic management of chronic conditions. It is considered relevant for managing symptom clusters that may become intense or disruptive in conditions such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis, acute Gouty Arthritis, intense Acute Low-Back Pain, and Primary Dysmenorrhea.

Proponol is used to help with symptoms related to physical discomfort, supporting patients during episodes of heightened distress. This supportive benefit is relevant for easing symptoms that interfere with daily functioning, supports patients during difficult episodes by easing distress and may help them cope more steadily with symptom fluctuations.

“It is commonly used to help with symptomatic management of conditions where functional stability becomes affected, applied across domains where additional symptomatic support is needed.”

Quick Fact: Symptomatic Relief Proponol is applied in addressing pronounced symptoms that may appear suddenly or persist chronically, assists with easing the overall symptom load caused by symptoms related to inflammatory or irritative states.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Proponol — official regulatory information

Populations for whom use is allowed (as stated in label):

  • Adults for the relief of symptoms related to Osteoarthritis and Rheumatoid Arthritis.

Populations for whom use is not recommended (if applicable):

  • Nursing Mothers (Clinical safety has not been established).
  • Women wishing to conceive (Use may affect female fertility).

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity to Proponol (piroxicam) or a history of allergic-type reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs.
  • Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Patients with active peptic ulcerations or a history of gastrointestinal ulceration, bleeding, or perforation.
  • Late-stage pregnancy (at or after 30 weeks gestation).
  • Patients with severe heart failure (e.g., NYHA II-IV, per some international labeling).

Age-related eligibility rules:

  • Pediatric Population: Safety and efficacy have not been established; use is not recommended.
  • Older Adults (Geriatric): Use requires caution due to a higher susceptibility to serious gastrointestinal and renal adverse effects.

Condition-specific eligibility rules:

  • Advanced Renal Disease: Avoid use unless benefits outweigh the risk of worsening renal function.
  • Volume Status: Dehydration must be corrected first before treatment initiation.
  • Hepatic or Renal Impairment: Requires close monitoring.

Connection to the overall eligibility profile: The regulatory documents establish that Proponol’s eligibility is defined by absolute exclusions primarily related to known NSAID risks, such as serious gastrointestinal and cardiovascular vulnerabilities, and an absolute ban in late-stage pregnancy. For otherwise eligible adults, use is conditional on the status of organ function (renal/hepatic) and mandates caution, particularly in the elderly population.

What should I know about interactions with other medicines?

Propranolol Interactions with Other Medicines and Products

Propranolol can interact with a wide range of medications, potentially altering its effect or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are currently taking before starting propranolol.

Significant Drug Interactions

Interactions that may require dose adjustment or close monitoring include those with other drugs that affect heart rate and blood pressure. Combining propranolol with certain calcium channel blockers (like verapamil or diltiazem) can lead to severely low heart rate or heart failure.

Interacting Drug Class Examples of Effects
Antiarrhythmics (e.g., amiodarone) Increased risk of bradycardia and heart block.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) May reduce the blood pressure-lowering effect of propranolol.
Monoamine Oxidase Inhibitors (MAOIs) Potential for significant changes in blood pressure.
Insulin and oral antidiabetic drugs Propranolol can mask the symptoms of low blood sugar (hypoglycemia), such as rapid heartbeat.
Adrenaline/Epinephrine The vasoconstrictive effect of epinephrine may be enhanced, leading to a severe increase in blood pressure.

Other Interactions

Alcohol can increase the sedative effects of propranolol and should be consumed in moderation or avoided. Products containing nicotine (e.g., smoking) may also lessen the effectiveness of propranolol by increasing heart rate and blood pressure.

Mechanism of Action

Enzymatic Inhibition of Prostanoid Production

The active ingredient, Piroxicam, functions as a non-selective inhibitor by binding reversibly to both the Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) enzymes. This interaction blocks the conversion of arachidonic acid into various prostanoids . This primary action attenuates the synthesis of prostanoids that function as signaling molecules in inflammatory cascades.


Modulation of Pain Signaling and Thermoregulation

By reducing the overall level of prostanoid mediators, the drug's mechanism leads to two distinct physiological consequences. Peripherally, it reduces the chemical sensitization of nociceptors, thereby increasing the activation threshold of nociceptors, which modifies peripheral pain signaling. Centrally, the suppression of PGE2 production in the hypothalamus facilitates the resetting of the hypothalamic temperature set point, thereby modulating the central component of the febrile response.

Dosage and Administration Information

Proponol (Piroxicam) is administered via the oral route (capsules or tablets) or by intramuscular (IM) injection. The administration schedule and dose are determined by the condition being managed and the duration of use.

For the chronic management of conditions such as Rheumatoid Arthritis or Osteoarthritis, the standard maintenance regimen is 20 mg taken once daily, or as a divided 10 mg dose twice daily. The maximum recommended daily dose for ongoing systemic use is 20 mg. In contrast, specific acute conditions require a short-term, higher loading dose. For instance, dosing for acute gout involves an initial 40 mg single dose followed by 40 mg daily for 4 to 6 days.

There are key contextual conditions for proper administration. Oral dosage forms are typically taken with or immediately after food or with a full glass of water. The long half-life of Piroxicam supports the typical once-daily frequency, but the benefit of the treatment course is to be reassessed within 14 days. Use of the IM injection route is limited to a short duration, generally 2 to 3 days, allowing a transition to the oral form. For older adults and patients with hepatic or renal impairment, the general principle of using the lowest effective dose for the shortest duration applies, often requiring lower doses to be considered.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Proponol


Evidence for Use in Osteoarthritis and Rheumatoid Arthritis

Proponol (Piroxicam) was evaluated in a large body of clinical research, primarily focusing on investigating symptoms related to these chronic inflammatory conditions. Researchers conducted numerous short-term Randomized Controlled Trials (RCTs) and meta-analyses that compared the medicine to placebo or to other medicines in the same class. These studies included adults diagnosed with chronic inflammatory conditions.

The research primarily evaluated how symptoms changed over defined time intervals, using validated indices to measure outcomes related to physical discomfort (like pain intensity) and to track outcomes reflecting daily functioning or activity level. The findings describe patterns observed in the studies, often reporting how symptom intensity evolved during the short follow-up periods.

However, the majority of the existing evidence for OA and RA consists of studies with limited follow-up durations. This means that long-term effects are not fully established, and evidence regarding the sustained patterns of symptom change over many years is not well-characterized by these initial research patterns.


Evidence for Use in Ankylosing Spondylitis and Localized Pain

Proponol was studied for investigating symptoms related to Ankylosing Spondylitis. The available research consists of RCTs and other prospective trials for this condition, monitoring outcomes specific to spinal symptoms, such as morning stiffness and various functional indices.

In a separate research area, the topical gel formulation of Proponol was evaluated in specific short-term RCTs focused strictly on acute or disruptive episodes linked to localized soft-tissue injuries. The research examined changes in localized pain and tenderness at the site of the injury. The study findings are restricted to the specific topical formulation and the short duration of acute injury episodes.


What Remains Unclear in the Research Evidence

The available evidence base, while extensive in areas like OA and RA, still presents several research limitation frames. There is limited information for long-term outcomes, and data for certain groups remain insufficient, notably for pediatric patients with Juvenile Idiopathic Arthritis. The evidence quality varies across studies, and while some studies report how symptoms evolved in the observed populations, the findings describe group patterns, not personal outcomes.

Key Studies & References NICE Clinical Guideline: Spondyloarthritis (including ankylosing spondylitis and psoriatic arthritis) management

Frequently Asked Questions (FAQ)

Common questions about Proponol (FAQ)

Q: How long does it typically take for a person to notice the effects of Proponol?

A: According to the official product information, while the medicine is absorbed relatively quickly, it may take up to two weeks for changes in symptoms to be observed. For the management of chronic inflammatory conditions, several weeks may pass before the overall effects are apparent.

Q: Can Proponol be used long-term, or is it only for short-term use?

A: Regulatory documents indicate that the medicine is used for the management of chronic conditions. However, a general principle across regulatory guidance emphasizes using the lowest effective dose for the shortest possible duration, with the need for continued treatment frequently reassessed by the prescribing professional.

Q: Are there any common foods or drinks I should avoid while taking Proponol?

A: Regulatory documents warn that the use of alcohol while taking this medicine may increase the risk of serious gastrointestinal side effects, such as stomach bleeding or ulcers.

Q: Can Proponol cause weight changes, like gain or loss?

A: Yes, regulatory documents list fluid retention or body swelling (edema) as a potential adverse effect, which may be associated with unusual weight gain. Loss of appetite has also been reported in clinical observations.

Q: Are there any known interactions between Proponol and alcohol?

A: Official warnings state that combining this medicine with alcohol may increase the risk of serious gastrointestinal complications, including stomach bleeding and ulceration.

Q: Is it normal to feel a bit light-headed when first starting Proponol?

A: Official product information lists dizziness as a known potential side effect. Studies analyzing adverse events suggest that these effects may be more likely to occur during the early stages of treatment.

Q: Does Proponol affect my ability to drive or operate machinery?

A: Because the medicine may cause central nervous system side effects such as dizziness or blurred vision, official prescribing information recommends caution. These effects could potentially impair a person’s ability to safely drive or operate heavy machinery.

Q: What happens if I miss a dose of Proponol?

A: If a dose is missed, patient guides describe that the dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patient guides emphasize that doubling the dose to compensate for a missed dose is not recommended.

Q: Is it true that Proponol can affect my blood sugar levels?

A: Official labeling states that the medicine should be used with caution in patients taking antidiabetic agents. This is because it may increase the risk of hypoglycemia (low blood sugar) or affect the body's response to blood sugar changes.

Q: Is Proponol safe to use if I have asthma or breathing problems?

A: Official regulatory documents indicate that the medicine is contraindicated (meaning use is prohibited based on label information) if a person has a history of asthma, hives, or other allergic-type reactions after taking aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Q: What are the most common but generally mild side effects of Proponol?

A: According to the official product information, common and generally mild side effects often include stomach discomfort or upset, acid or sour stomach, nausea, belching, and passing gas.

Q: Can Proponol interact with over-the-counter pain relievers like ibuprofen?

A: Official warnings state that taking this medicine with other NSAIDs, including ibuprofen, is not recommended. This caution relates to the cumulative risk of serious gastrointestinal adverse events, such as stomach ulcers and bleeding.

Q: What is the risk of dependence or addiction with Proponol?

A: Official governmental classifications indicate that this medicine is not a controlled substance. It is not known to carry a risk of dependence or addiction.

Q: Can taking Proponol make me feel more tired or dizzy?

A: Reported side effects include central nervous system effects such as dizziness and somnolence (tiredness or drowsiness). If these effects occur, caution is advised.

Q: Does Proponol have an official pregnancy safety category classification?

A: Regulatory documents indicate that the medicine has a legacy FDA Pregnancy Category C prior to 30 weeks of gestation. The drug is contraindicated (use is prohibited) from 30 weeks onward due to potential risks to the fetus.

Q: Can Proponol cause issues with sleep or cause strange dreams?

A: Official information indicates that central nervous system adverse events have been reported, including sleep disturbances, restlessness, and mood alterations.

Q: Is Proponol available as a generic medicine?

A: Yes, regulatory records indicate that a therapeutically equivalent generic version of the active ingredient is approved and available.

Q: Is Proponol used for any conditions that affect the thyroid gland?

A: The medicine is not indicated (approved for use) in thyroid conditions. However, studies show that while the medicine does not interfere with free T4 and T3 hormone levels, it may affect the laboratory measurement of these thyroid hormones.

Q: What interactions are noted between Proponol and herbal supplements?

A: Official warnings note that interactions may occur with herbal or nutraceutical products that have antiplatelet (blood-thinning) effects. Examples cited include products like American ginseng or alfalfa, as co-use could potentially increase the risk of bleeding.

Q: How is Proponol typically studied in clinical trials?

A: Clinical efficacy and safety are typically evaluated through short-term Randomized Controlled Trials (RCTs) and meta-analyses. These studies are conducted in adult patients focusing on measuring changes in symptoms related to inflammatory conditions.

Q: Is Proponol considered safe for older adults (seniors)?

A: Official prescribing information states that older adults are at greater risk for serious side effects, particularly gastrointestinal bleeding and kidney problems. The use of the drug in this population requires careful monitoring by a health professional.

Q: How is Proponol different from a tranquilizer or anti-anxiety medicine?

A: Proponol is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), and its purpose is to relieve pain and swelling. It is fundamentally different from a tranquilizer or anti-anxiety medicine and is not classified as a controlled substance.

Q: Are there any major drug-to-drug interactions that are commonly highlighted in official warnings?

A: Official warnings highlight significant interactions when co-used with anticoagulants (blood thinners), other NSAIDs, corticosteroids, and certain antidepressants (SSRIs/SNRIs). These combinations are noted for increasing the risk of serious gastrointestinal bleeding or complications.

Q: Do studies mention any differences in how Proponol affects men versus women?

A: Post-marketing safety analyses suggest that NSAID-related hepatotoxicity (liver injury) may be more common among women and the elderly. Adverse event patterns can therefore vary based on sex and age.

Q: Can Proponol cause a rash or other skin reactions?

A: Yes, official adverse event listings mention that the medicine can cause skin reactions, ranging from simple rashes and hives to rare, severe, and potentially fatal reactions like Stevens-Johnson Syndrome (SJS).

Q: If I am taking medication for depression, can I also take Proponol?

A: Official warnings state that co-use with Selective Serotonin Re-uptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Re-uptake Inhibitors (SNRIs) increases the risk of gastrointestinal bleeding, which is a factor that requires caution.

Q: What are some less common but serious side effects described in official drug information?

A: Major official warnings highlight serious, less common side effects including an increased risk of heart attack or stroke, severe gastrointestinal bleeding or ulceration, and severe allergic reactions (anaphylaxis).

Q: What are the documented effects of Proponol on vision?

A: Adverse effects related to vision have been reported in official product information, including blurred vision and, in rare instances, changes in central vision.

Q: What do official sources say about the use of Proponol during breastfeeding?

A: Official regulatory information confirms that the drug is excreted into human milk. Scientific literature and regulatory documents advise the health professional to weigh the potential benefits of use against the risk of exposure to the nursing infant.

How should Proponol be stored and disposed of?

How to Store and Dispose of Proponol (Piroxicam)

Proponol (Piroxicam) must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The medication must be protected from light and moisture and should not be stored in areas of excess heat. It must be kept in its tight, light-resistant container and the container must be securely closed.

All Proponol should be kept out of the sight and reach of children to prevent accidental ingestion. Disposal of unused or expired product must be done in accordance with local regulations.


Storage Requirement Condition
Temperature Range 20 C to 25 C (CRT)
Environmental Protection Protect from light and moisture
Container Rule Must be tight and light-resistant
Child Safety Keep out of sight and reach of children

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proponol found in:

A-Z Index: